A microdose is defined by what it does not do: it is a quantity of psilocybin small enough that no acute psychedelic effect is felt. In common usage, this falls at roughly 0.05 to 0.3 grams of dried mushroom, with amounts around this range commonly appearing in self-reported microdosing practice — but the gram figure is secondary to the threshold. The defining test is perceptual, not numerical: if you notice a psychedelic effect, the amount has crossed out of the microdose range, regardless of the weight. This separates a microdose from both a low recreational dose, which is meant to be felt, and a full dose, which is overtly perceptual.
Why this matters
The single most common error in discussions of microdosing is treating it as “a small recreational dose.” It is not, and the difference is definitional rather than a matter of degree. A microdose is intentionally below the perceptual threshold; the entire premise is that nothing acute is felt. Getting this wrong leads people to take too much, to expect a noticeable lift, and to misread the research — which studies a sub-perceptual practice, not a mild high. A shorter version of this definition appears in the 90-second summary on iMicrodosing.net.
The threshold, not the number
The popular literature describes a microdose as an amount below the threshold of noticeable acute effects. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023 That is the operative definition. The commonly cited range — about 0.05 to 0.3 grams of dried Psilocybe mushroom, with amounts near this range frequently reported in observational literature — is a practical convenience derived from where most people find that threshold sits, not a pharmacological constant. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
Two factors make the gram figure unreliable on its own. First, psilocybin content varies substantially between mushroom species and even between specimens of the same species, so a fixed weight does not correspond to a fixed amount of active compound. This variability means two visually similar samples of dried mushroom material may contain meaningfully different amounts of active compounds, making weight an imperfect proxy for pharmacological exposure. Second, individual sensitivity differs, so the same quantity may be sub-perceptual for one person and faintly perceptual for another. For both reasons, the threshold — did you feel anything? — is the definition, and the gram range is a starting estimate to be calibrated against that threshold.
What “sub-perceptual” means
Sub-perceptual means that the characteristic acute features of a psychedelic dose are absent: no visual changes, no perceptual distortion, no euphoria or dissociation, and — most people report — no impairment of ordinary daytime function. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023 If any of these appear, the amount is, by the definition itself, no longer a microdose.
This is why the practice is described as cumulative and retrospective rather than acute. The reported effect is not a state entered on a dose day; it is a pattern noticed, if at all, across weeks of consistent self-observation. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023 A microdose that produced a clearly felt acute effect would defeat its own definition.
Sub-perceptual does not mean inactive
A dose being below conscious psychedelic perception does not automatically mean nothing is happening biologically. It only means the characteristic acute psychedelic experience is absent. Whether changes below that threshold translate into measurable psychological or behavioral outcomes remains an active research question — and it is precisely the question that distinguishes a coherent biological rationale from a demonstrated effect.
How a microdose differs from adjacent doses
It helps to place a microdose on a spectrum against the two doses it is most often confused with.
| Microdose | Low recreational dose | Full dose | |
|---|---|---|---|
| Intended experience | None felt (sub-perceptual) | Mild but noticeable effect | Overt, immersive psychedelic effect |
| Typical dried-mushroom range | ~0.05-0.3 g | ~0.5-1.5 g | ~2-5 g or more |
| Pattern of use | Structured, repeating schedule | Occasional | Occasional, often a single session |
| Effect timing | Cumulative, noticed over weeks | Acute, hours | Acute, hours |
| Current evidence base | Observational studies + limited controlled trials | Less clearly defined research category | Controlled clinical research primarily examines supervised perceptual dosing |
The ranges shown are descriptive of common usage, not safety guidance, and the boundaries are soft because they depend on the individual and the material. The important structural point is that these are three different interventions, not three points on a single dial of intensity. A low recreational dose is meant to be felt; a microdose is meant not to be. Among the strongest psilocybin research is full-dose clinical work — but that evidence describes a perceptual intervention and does not transfer downward to the sub-perceptual band. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
The role of the schedule
A microdose is rarely a one-off. In common usage the dose is embedded in a repeating schedule, the most referenced of which is the pattern popularized in 2011: one dose day, two days off, repeat. [3] Practitioner The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys Link → The schedule exists because the reported effect is cumulative; a single sub-perceptual dose is, by design, not expected to produce a noticeable change. This scheduling is part of what makes microdosing a practice rather than an event, and it is also part of why it is difficult to study — the structure invites consistent expectation, which the observational data cannot fully separate from the dose itself. [4] Observational Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls doi:10.1038/s41598-022-14512-3
- Perceptual threshold
- The boundary above which a psychedelic effect becomes noticeable. A microdose is defined as sitting below it. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
- Dose-content mismatch
- Because psilocybin concentration varies between mushrooms, a fixed weight does not equal a fixed amount of active compound — one reason the gram figure is only a starting estimate.
- Three distinct interventions
- Microdose, low recreational dose, and full dose differ in intent and effect, not merely in size; results from one band do not transfer to another. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
Frequently asked questions
Is 0.15 grams the correct microdose?
It is an amount commonly reported in popular and survey literature, not a fixed correct value or a recommendation. Psilocybin content varies between mushrooms and individuals differ in sensitivity, so the meaningful criterion is whether the amount stays below the perceptual threshold — not the specific weight. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
Is a microdose the same for everyone?
No. A fixed weight does not produce identical exposure across individuals, because mushroom composition varies and people differ biologically. This is why research defines microdosing by the sub-perceptual threshold rather than only by weight. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
If I feel a mild effect, is that still a microdose?
By the standard definition, no. A microdose is sub-perceptual; a noticeable effect, even a mild one, indicates the amount has crossed into a low perceptible dose rather than a microdose. The two are different categories, not the same thing at slightly different strengths. [1] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
Why is a microdose taken on a schedule rather than as needed?
Because the reported effect is described as cumulative rather than acute. A single sub-perceptual dose is not expected to produce a felt change; the structured, repeating schedule is what defines microdosing as an ongoing practice. [3] Practitioner The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys Link →
Does full-dose psilocybin research tell us about microdosing?
Only indirectly. Full-dose studies describe an overtly perceptual intervention, and their results do not transfer to sub-perceptual amounts, which engage the same receptor system but at a different scale and in a different context. Microdose claims need microdose evidence. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
In summary
A microdose is best defined by its defining absence: an amount of psilocybin small enough that no acute psychedelic effect is felt. The commonly cited 0.05-0.3 gram range, and the amounts most often reported within it, are practical estimates of where that sub-perceptual threshold tends to fall, not a recommended dose or the definition itself. A microdose differs in kind, not just in size, from a low recreational dose and from a full dose, and it is typically embedded in a structured schedule because its reported effects are cumulative rather than acute. Keeping the definition anchored to the perceptual threshold, rather than to a number, is what keeps the rest of the field’s claims legible.